Debra Hughes, MS, Author at MPR - Page 3 of 40

Debra Hughes, MS

All articles by Debra Hughes, MS

Does Concomitant PPI Use Affect Efficacy of Elbasvir/Grazoprevir?

Consistent concomitant use of proton pump inhibitors (PPIs) with elbasvir/grazoprevir (EBR/GZR) had no clinically significant effect on 12-week sustained viral response (SVR12) rates in patients with hepatitis C virus (HCV) genotype (GT)1 or GT4 infection with and without cirrhosis, according to research presented at The Liver Meeting® 2016

Sofosbuvir + Ribavirin Effective in Teens With HCV GT 2/3

For adolescents with chronic hepatitis C virus (HCV) infection, treatment with sofosbuvir (SOF) and ribavirin (RBV) led to a 98% SVR12 rate with no virologic failures, reported Kathleen B. Schwarz, MD, a professor of pediatrics at Johns Hopkins University School of Medicine, Baltimore, MD, at The Liver Meeting® 2016.